Answers are grounded in this paper and cite their sources.
This JAMA Insights Clinical Update reviews indications and timing of insulin therapy for management of type 2 diabetes, emphasizing the likely benefit of its use as first-line therapy in patients with HbA1c levels less than 9.0%.
No takes yet. Share an insight, caveat, or question.
Hirsch et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: